Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
UB

OTC · UBQU

Ubiquitech Software Corp.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Up+$0.00 (+0.00%)

Updated Oct 12, 2026, 6:39 AM

SID Score

3.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.59M
P/E ratio
4.6
Dividend yield
0.00%
52-week range
— – —
Volume
100
Avg. volume
1.16M

Price performance · UBQU

UBQU price history

1M range · 0 trading sessions · Daily adjusted prices

UBQU does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest UBQU news

The latest Smart Investors Daily articles mentioning UBQU.

Stock researchCompany · Overview

UBQU research

Overview

Company profile and research snapshot.

Company profile

UBIQUITECH SOFTWARE CORP

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Apr 23, 2024

Ubiquitech Software Corporation Reports Total Convertible Debt Reduction in Excess of $1,700,000 During Past 12 Months

DENVER, CO, April 23, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU), a trailblazer in innovative software development, is pleased to announce that during its fiscal second quarter, an additional $700,000 of convertible debt principal and accrued interest has been eliminated from the corporate balance sheet.  This brings the total convertible debt reduction over the past twelve months to over $1,700,000. The final numbers will be reflected in the company’s financial statements filed with OTCMarkets.com on or before July 15, 2024.

GlobeNewswire Inc. · Apr 10, 2024

Ubiquitech Software's Subsidiary, Innovative Outcomes, Revolutionizes Healthcare Landscape With Clinic-Based Model, Anticipates Surge in Revenue Growth

DENVER, CO, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU), an innovative force in software development, is proud to announce a game-changing initiative by its subsidiary, Innovative Outcomes. The addition of a “Clinic-Based” focus to its business model represents a new era of exponential revenue growth, with each "Clinic Model" poised to inject an additional one million dollars annually into Innovative Outcomes' revenue stream.

GlobeNewswire Inc. · Apr 5, 2024

Innovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market

DENVER, CO, April 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to announce that its subsidiary, Innovative Outcomes, Inc., has entered into a distribution agreement with MDM Wound Ventures to distribute its new wound debriding system called EZE Debride to healthcare professionals throughout the US, and beyond.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By